Lessons from look-back in acute liver failure? A single centre experience of 3300 patients.

PubWeight™: 1.83‹?› | Rank: Top 3%

🔗 View Article (PMID 23439263)

Published in J Hepatol on February 22, 2013

Authors

William Bernal1, Anna Hyyrylainen, Amit Gera, Vinod K Audimoolam, Mark J W McPhail, Georg Auzinger, Mohammed Rela, Nigel Heaton, John G O'Grady, Julia Wendon, Roger Williams

Author Affiliations

1: Liver Intensive Therapy Unit, Institute of Liver Studies, Kings College Hospital, London, United Kingdom. william.bernal@kcl.ac.uk

Articles citing this

Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation. J Clin Exp Hepatol (2014) 0.91

Molecular pathophysiology of cerebral edema. J Cereb Blood Flow Metab (2015) 0.89

Pathophysiology of cerebral oedema in acute liver failure. World J Gastroenterol (2013) 0.87

Acute-on-chronic liver failure: terminology, mechanisms and management. Nat Rev Gastroenterol Hepatol (2016) 0.82

Acute liver failure and liver transplantation. Intractable Rare Dis Res (2013) 0.81

Nationwide longitudinal analysis of acute liver failure in taiwan. Medicine (Baltimore) (2014) 0.78

Acute liver failure: current trends. J Hepatol (2013) 0.78

Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States. Liver Transpl (2016) 0.77

Murine model to study brain, behavior and immunity during hepatic encephalopathy. World J Hepatol (2014) 0.77

Acute Liver Injury Is Independent of B Cells or Immunoglobulin M. PLoS One (2015) 0.77

A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases. PLoS One (2016) 0.75

Epstein-Barr Virus-Associated Acute Liver Failure Present in a 67-Year-Old Immunocompetent Female. Gastroenterology Res (2016) 0.75

Clinical management of acute liver failure: Results of an international multi-center survey. World J Gastroenterol (2016) 0.75

Liver transplantation in acute liver failure: A challenging scenario. World J Gastroenterol (2016) 0.75

Development and Pilot of a Checklist for Management of Acute Liver Failure in the Intensive Care Unit. PLoS One (2016) 0.75

Hepatobiliary Quiz (Answers)-14 (2015). J Clin Exp Hepatol (2015) 0.75

Improved prescription of taohechengqi-tang alleviates D-galactosamine acute liver failure in rats. World J Gastroenterol (2016) 0.75

Role of inflammation and infection in the pathogenesis of human acute liver failure: Clinical implications for monitoring and therapy. World J Gastroenterol (2016) 0.75

Validation of the Model for End-Stage Liver Disease Score Criteria in Urgent Liver Transplantation for Acute Flare Up of Hepatitis B. Medicine (Baltimore) (2016) 0.75

Living Donor Liver Transplantation for Acute Liver Failure With Fixed Pupils: Are We Fixed? J Clin Exp Hepatol (2016) 0.75

Acute Liver Failure Due to Hepatitis E Virus Infection Is Associated with Better Survival than Other Etiologies in Indian Patients. Dig Dis Sci (2017) 0.75

Interleukin-1α and Interleukin-1β play a central role in the pathogenesis of fulminant hepatic failure in mice. PLoS One (2017) 0.75

The Natural History of Severe Acute Liver Injury. Am J Gastroenterol (2017) 0.75

Articles by these authors

Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions. Intensive Care Med (2006) 7.26

Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology (2013) 5.88

Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations. Intensive Care Med (2007) 4.40

Acute liver failure. N Engl J Med (2013) 3.88

Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet (2002) 3.73

Acute liver failure. Lancet (2010) 3.39

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet (2014) 3.12

Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening. Hepatology (2008) 2.98

EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis. Gastrointest Endosc (2012) 2.92

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut (2012) 2.91

Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology (2012) 2.81

Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival. Liver Transpl (2007) 2.59

Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol (2004) 2.48

Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology (2007) 2.32

Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood (2009) 2.30

Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol (2004) 2.28

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2004) 2.23

Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis (2003) 2.17

Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology (2013) 2.08

Paracetamol: are therapeutic doses entirely safe? Lancet (2006) 2.07

Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl (2013) 2.05

Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl (2003) 2.01

Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl (2002) 2.00

Old versus new antiepileptic drugs: the SANAD study. Lancet (2007) 1.99

3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet (2006) 1.97

Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology (2009) 1.94

Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Liver Transpl (2006) 1.82

Mucinous cystic neoplasms of the liver: a clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct. Mod Pathol (2011) 1.74

Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol (2003) 1.73

The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology (2004) 1.71

Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med (2002) 1.66

'Nipped in the Budd': hepatic venous outflow obstruction in evolution. Eur J Gastroenterol Hepatol (2005) 1.66

Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol (2012) 1.66

Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors. J Neurooncol (2003) 1.63

ESPEN Guidelines on Parenteral Nutrition: hepatology. Clin Nutr (2009) 1.63

Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol (2005) 1.60

Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology (2003) 1.59

Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology (2003) 1.59

Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range. Liver Transpl (2004) 1.58

Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis. J Hepatol (2002) 1.57

Liver transplantation for propionic acidemia in children. Liver Transpl (2011) 1.56

The impact of organ dysfunction in cirrhosis: survival at a cost? J Hepatol (2012) 1.52

Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology (2006) 1.51

Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure*. Crit Care Med (2013) 1.51

Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl (2004) 1.50

Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation. Liver Int (2013) 1.50

Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study. Crit Care Med (2006) 1.50

Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease. Am J Hematol (2009) 1.48

Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation. Liver Transpl (2013) 1.48

Primary pancreatic lymphoma: diagnostic and therapeutic dilemma. Pancreas (2006) 1.47

Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis. Hepatology (2013) 1.47

Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl (2005) 1.47

Phosphoinositide 3-kinases as drug targets in cancer. Curr Opin Pharmacol (2005) 1.47

Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol (2003) 1.45

Binding of bilirubin and bromosulphthalein to albumin: implications for understanding the pathophysiology of liver failure and its management. Liver Transpl (2004) 1.43

Diaphragmatic dysfunction after pediatric orthotopic liver transplantation. Transplantation (2002) 1.43

Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology (2002) 1.41

Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs. Intensive Care Med (2004) 1.41

Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia. Am J Hematol (2005) 1.41

Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif (2002) 1.41

Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg (2004) 1.39

Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med (2008) 1.38

Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy. Blood (2002) 1.34

Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control. Antiviral Res (2003) 1.31

Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology (2006) 1.30

CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol (2009) 1.27

Spontaneous rupture of hepatocellular carcinoma: a Western experience. Am J Surg (2008) 1.25

The pathophysiological basis of acute-on-chronic liver failure. Liver (2002) 1.24

Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy. J Hepatol (2005) 1.23

Protocols and mechanisms for remote ischemic preconditioning: a novel method for reducing ischemia reperfusion injury. Transplantation (2007) 1.22

Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Hepatology (2004) 1.21

The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology (2002) 1.19

The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol (2007) 1.16

ARAP3 is a PI3K- and rap-regulated GAP for RhoA. Curr Biol (2004) 1.15

Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity. Hepatology (2005) 1.15

Diagnostic value of Doppler assessment of the hepatic and portal vessels and ultrasound of the spleen in liver disease. Eur J Gastroenterol Hepatol (2004) 1.14

Alpha-fetoprotein impairs APC function and induces their apoptosis. J Immunol (2004) 1.13

Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative? Transplantation (2015) 1.13

Management of neuroendocrine liver metastases. Am J Surg (2004) 1.13

Liver transplantation for Budd-Chiari syndrome. Transplantation (2002) 1.12

Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. Anal Chem (2005) 1.11

Pseudoaneurysm following laparoscopic cholecystectomy. Hepatobiliary Pancreat Dis Int (2007) 1.10

Emergency liver transplantation following severe liver trauma. Liver Transpl (2008) 1.09

Nutrition in end-stage liver disease: principles and practice. Gastroenterology (2008) 1.08

 Review of the neurological manifestations of hepatitis E infection. Ann Hepatol (2012) 1.08

Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients. J Infect Dis (2004) 1.08

Reply: To PMID 22334567. Hepatology (2013) 1.08

Ruptured hepatocellular carcinoma following chemoembolization: a western experience. Hepatobiliary Pancreat Dis Int (2007) 1.08